跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,971 条关于
“PI3-kinase delta”
全部
5,971
临床试验
3,109
药物
823
机构
49
资讯
1,990
去年
First European Patient Receives Breakthrough Treatment for Ultra-Rare APDS Immune Disorder
上个月
Cancer Research Horizons' Charity Capital Model Targets Broken Childhood Cancer Market After $1.5B Myricx Exit
去年
FDA Approves Yingli Pharma's Phase III Trial for Novel PTCL Treatment Linperlisib
3个月前
EMA Grants Conditional Approval for Vijoice, First Treatment for Rare PIK3CA-Related Overgrowth Disorders
去年
JAK Inhibitor Pipeline Shows Promise for Autoimmune and Inflammatory Diseases
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Improves Survival in HR+/HER2- Advanced Breast Cancer
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Significantly Improve Outcomes in Advanced Breast Cancer
10个月前
BriaCell Partners with Receptor.AI to Develop AI-Driven Cancer Kinase Inhibitors
9个月前
Kinase Inhibitors Discovered to Trigger Widespread Protein Degradation Beyond Traditional Inhibition
去年
Puma Biotechnology Acquires Takeda's Aurora Kinase Inhibitor Alisertib for $7M Upfront
第 1 页,共 199 页
上一页
下一页